TP53-Mutated Myelodysplastic Syndrome and Acute Myeloid Leukemia: Biology, Current Therapy, and Future Directions

Investigators discuss recent insights into the biology of TP53-mutated myelodysplastic syndrome and AML, current treatments, and emerging therapies, including immunotherapeutic and nonimmune-based approaches for this entity.